Coastal Urology Associates

Brick, New Jersey 08723

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
High-risk Non-muscle Invasive Bladder Cancer Clinical Trial
Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Status: Enrolling, Phase III
Updated: 12/31/1969
Coastal Urology Associates
mi
from
Brick, NJ
Click here to add this to my saved trials